| __timestamp | BioCryst Pharmaceuticals, Inc. | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 23068000 |
| Thursday, January 1, 2015 | 46361000 | 33277000 |
| Friday, January 1, 2016 | 23654000 | 184902000 |
| Sunday, January 1, 2017 | 23484000 | 437411000 |
| Monday, January 1, 2018 | 20182000 | 827478000 |
| Tuesday, January 1, 2019 | 44734000 | 934678000 |
| Wednesday, January 1, 2020 | 16136000 | 951266000 |
| Friday, January 1, 2021 | 149906000 | 1382097000 |
| Saturday, January 1, 2022 | 264233000 | 1553153000 |
| Sunday, January 1, 2023 | 326751000 | 1757661000 |
| Monday, January 1, 2024 | 2168701000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, financial performance is a key indicator of a company's potential. Over the past decade, Exelixis, Inc. and BioCryst Pharmaceuticals, Inc. have shown contrasting trajectories in their gross profit margins. From 2014 to 2023, Exelixis has consistently outperformed BioCryst, with a staggering 7.6-fold increase in gross profit, peaking at $1.76 billion in 2023. In contrast, BioCryst's growth, while notable, has been more modest, achieving a 24-fold increase to $327 million in the same period.
The year 2021 marked a significant turning point for both companies. Exelixis saw a 40% surge in gross profit, while BioCryst experienced a remarkable 76% increase. These trends highlight the competitive nature of the biotech industry and underscore the importance of strategic innovation and market adaptation. As we look to the future, these companies' financial health will be pivotal in shaping their market positions.
Gross Profit Comparison: Gilead Sciences, Inc. and Exelixis, Inc. Trends
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Catalent, Inc. vs Exelixis, Inc.
Exelixis, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Exelixis, Inc. or Travere Therapeutics, Inc.
Exelixis, Inc. or BioCryst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Selling, General, and Administrative Costs: Exelixis, Inc. vs BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Pharming Group N.V. or BioCryst Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown